Columnists
SARS-CoV-2 (orange) -- also known as 2019-nCoV, the virus that causes COVID-19. Image: NIAID/Flickr
Linda McQuaig | For seven decades, Connaught Labs performed brilliantly on the national and international stage, contributing to medical breakthroughs and developing affordable treatments and vaccines.
News
Image: DraconianRain/Flickr
Adam R. Houston | Drug companies need to offer their wares at a fair price for everyone, everywhere, rather than letting some patients draw lots for a shot at life while keeping the financial jackpot for themselves.
News
Image: Jamie/Flickr
Ed Finn | Federal and most provincial governments continue to deny many thousands of citizens the basic preventive and protective health services that are standard practice in most other advanced nations.
Podcast
Image: Wikimedia Commons/Tom Varco
Redeye Collective | A national pharmacare program would save the health-care system billions and improve the health of the one in 10 Canadians who can't afford the medication they are prescribed.
RabbleTV
Shit Harper Did | An American pharmaceutical corporation is suing Canadian taxpayers for $500 million because we rejected their patents.
Podcast
Frieda Werden | Should the women's movement buy into sex drugs? Dr. Leonore Tiefer speaks at a conference on the medicalization of sex.
Columnists
Jim Stanford | Canada's outstanding work to invent the world's most promising vaccine against Ebola perfectly epitomizes both the promise of public research, and the perverse incentives of the for-profit industry.
Blog
Stuart Trew | Médecins Sans Frontières is calling on the U.S. to revise its intellectual property demands in the TPP trade deal or watch it become "the most harmful trade deal ever for access to medicines."
RabbleTV
rabbleTV | On September 19, 200 people froze in the streets of Geneva to protest the attack on generic medicines by Swiss pharmaceutical company Novartis. Watch to see how passersby reacted.
Blog
Photo: e-Magine Art/Flickr
Guillaume Hebert | The time has come to assess how effective policies regarding the pharmaceutical industry are. For some 20 years, Quebec has put everything in place to attract giants of this powerful industry.
Columnists
Ralph Surette | Drug costs are the fastest-rising part of a public system said to be heading for the rocks, but are equally tough on private drug plans, which account for over half of drug spending in Canada.
Podcast
Jane Williams | Women have good reason to be wary of prescription drugs after decades of poorly-tested drugs from thalidomide 50 years ago to HRT now. A new book tackles women and drug policy in Canada.